cyproterone acetate has been researched along with Carcinoma, Squamous Cell in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kleemann, D | 2 |
Lotti, T; Montironi, R; Polito, M; Prezioso, D | 1 |
1 trial(s) available for cyproterone acetate and Carcinoma, Squamous Cell
Article | Year |
---|---|
Leuprorelin 1-month depot as neoadjuvant therapy for prostate cancer. Takeda NHT Italian Group.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cyproterone Acetate; Delayed-Action Preparations; Diagnosis, Differential; Disease-Free Survival; Drug Administration Schedule; Humans; Leuprolide; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Prostatectomy; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms | 1998 |
2 other study(ies) available for cyproterone acetate and Carcinoma, Squamous Cell
Article | Year |
---|---|
[Testosterone versus dihydrotestosterone effects on permanent squamous epithelial cancer cell lines of the larynx].
Topics: Carcinoma, Squamous Cell; Cell Division; Cell Line; Cyproterone Acetate; Dihydrotestosterone; Dose-Response Relationship, Drug; Humans; Laryngeal Neoplasms; Male; Testosterone; Tumor Cells, Cultured | 1993 |
[On the dependency of larynx carcinoma on steroid sex hormones].
Topics: Animals; Carcinoma, Squamous Cell; Cell Division; Cyproterone Acetate; Female; Humans; Laryngeal Neoplasms; Male; Mice; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Precancerous Conditions; Receptors, Androgen; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 2002 |